跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SEQ-400
首页
药物
SEQ-400
SEQ-400
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Immunoglobulin binding protein
申请人: AFFITECH AS
优先权: 1998
US
2 件公开
Compositions and methods for treating alzheimer's disease
申请人: CANGENE U S INC
优先权: 2012
CN
COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE
申请人: CANGENE U S INC
优先权: 2012
US
Deletion mutant of a set of hepatitis B HBx gene and application thereof
申请人: ZHU PINGAN
优先权: 2007
CN
Polynucleotides and polypeptide of human KV1.3, compositions comprising same and methods of using same
申请人: BRESLER TAL
优先权: 2006
US
2 件公开
Muller cell-specific promoter
申请人: ROSKA BOTOND
优先权: 2014
US
Promoter for the specific expression of genes in Müller cells
申请人: FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RES
优先权: 2015
US
SYNP159, a promoter for the specific expression of genes in rod photoreceptors
申请人: FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RES
优先权: 2015
US
2 件公开
药物
反馈